TY - JOUR AU - Cohn, J. S. AU - Marcoux, C. AU - Davignon, J. PY - 1999 DA - 1999// TI - Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins JO - Arterioscler Thromb Vasc Biol VL - 19 UR - https://doi.org/10.1161/01.ATV.19.10.2474 DO - 10.1161/01.ATV.19.10.2474 ID - Cohn1999 ER - TY - JOUR AU - Brunzell, J. D. AU - Davidson, M. AU - Furberg, C. D. AU - Goldberg, R. B. AU - Howard, B. V. AU - Stein, J. H. AU - Witztum, J. L. PY - 2008 DA - 2008// TI - American Diabetes Association; American College of Cardiology foundation. Lipoprotein management in patients with cardiometabolic risk. Consensus statement from the American Diabetes Association and the American College of Cardiology foundation JO - Diabetes Care VL - 31 UR - https://doi.org/10.2337/dc08-9018 DO - 10.2337/dc08-9018 ID - Brunzell2008 ER - TY - JOUR AU - Fujioka, Y. AU - Ishikawa, Y. PY - 2009 DA - 2009// TI - Remnant lipoproteins as strong key particles to atherogenesis JO - J Atheroscler Thromb VL - 16 UR - https://doi.org/10.5551/jat.E598 DO - 10.5551/jat.E598 ID - Fujioka2009 ER - TY - JOUR AU - Kannel, W. B. AU - Vasan, R. S. PY - 2009 DA - 2009// TI - Triglycerides as vascular risk factors: new epidemiologic insights JO - Curr Opin Cardiol VL - 24 UR - https://doi.org/10.1097/HCO.0b013e32832c1284 DO - 10.1097/HCO.0b013e32832c1284 ID - Kannel2009 ER - TY - JOUR AU - Hermans, M. P. AU - Fruchart, J. C. PY - 2010 DA - 2010// TI - Reducing residual vascular risk in patients with atherogenic dyslipidaemia: where do we go from here? JO - Clin Lipidol VL - 5 UR - https://doi.org/10.2217/clp.10.65 DO - 10.2217/clp.10.65 ID - Hermans2010 ER - TY - JOUR AU - Sarwar, N. AU - Sandhu, M. S. AU - Ricketts, S. L. AU - Butterworth, A. S. AU - Di Angelantonio, E. AU - Boekholdt, S. M. AU - Ouwehand, W. AU - Watkins, H. AU - Samani, N. J. AU - Saleheen, D. AU - Lawlor, D. AU - Reilly, M. P. AU - Hingorani, A. D. AU - Talmud, P. J. AU - Danesh, J. PY - 2010 DA - 2010// TI - Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(10)60545-4 DO - 10.1016/S0140-6736(10)60545-4 ID - Sarwar2010 ER - TY - JOUR AU - Jacobson, T. A. PY - 2011 DA - 2011// TI - Opening a new lipid “apo-thecary”: incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk JO - Mayo Clin Proc VL - 86 UR - https://doi.org/10.4065/mcp.2011.0128 DO - 10.4065/mcp.2011.0128 ID - Jacobson2011 ER - TY - JOUR AU - Langsted, A. AU - Freiberg, J. J. AU - Tybjaerg-Hansen, A. AU - Schnohr, P. AU - Jensen, G. B. AU - Nordestgaard, B. G. PY - 2011 DA - 2011// TI - Non-fasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City heart study with 31 years of follow-up JO - J Intern Med VL - 270 UR - https://doi.org/10.1111/j.1365-2796.2010.02333.x DO - 10.1111/j.1365-2796.2010.02333.x ID - Langsted2011 ER - TY - JOUR AU - Jørgensen, A. B. AU - Frikke-Schmidt, R. AU - West, A. S. AU - Grande, P. AU - Nordestgaard, B. G. AU - Tybjærg-Hansen, A. PY - 2013 DA - 2013// TI - Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction JO - Eur Heart J VL - 34 UR - https://doi.org/10.1093/eurheartj/ehs431 DO - 10.1093/eurheartj/ehs431 ID - Jørgensen2013 ER - TY - JOUR AU - McPherson, R. PY - 2013 DA - 2013// TI - Remnant cholesterol: “Non-(HDL-C + LDL-C)” as a coronary artery disease risk factor JO - J Am Coll Cardiol VL - 61 UR - https://doi.org/10.1016/j.jacc.2012.11.009 DO - 10.1016/j.jacc.2012.11.009 ID - McPherson2013 ER - TY - JOUR AU - Varbo, A. AU - Benn, M. AU - Tybjærg-Hansen, A. AU - Jørgensen, A. B. AU - Frikke-Schmidt, R. AU - Nordestgaard, B. G. PY - 2013 DA - 2013// TI - Remnant cholesterol as a causal risk factor for ischemic heart disease JO - J Am Coll Cardiol VL - 61 UR - https://doi.org/10.1016/j.jacc.2012.08.1026 DO - 10.1016/j.jacc.2012.08.1026 ID - Varbo2013 ER - TY - JOUR AU - Zambon, A. AU - Puato, M. AU - Faggin, E. AU - Grego, F. AU - Rattazzi, M. AU - Pauletto, P. PY - 2013 DA - 2013// TI - Lipoprotein remnants and dense LDL are associated with features of unstable carotid plaque: a flag for non-HDL-C JO - Atherosclerosis VL - 230 UR - https://doi.org/10.1016/j.atherosclerosis.2013.06.024 DO - 10.1016/j.atherosclerosis.2013.06.024 ID - Zambon2013 ER - TY - JOUR AU - Fruchart, J. C. AU - Duriez, P. PY - 2002 DA - 2002// TI - HDL and triglyceride as therapeutic targets JO - Curr Opin Lipidol VL - 13 UR - https://doi.org/10.1097/00041433-200212000-00003 DO - 10.1097/00041433-200212000-00003 ID - Fruchart2002 ER - TY - JOUR AU - Friedewald, W. T. AU - Levy, R. I. AU - Fredrickson, D. S. PY - 1972 DA - 1972// TI - Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge JO - Clin Chem VL - 18 ID - Friedewald1972 ER - TY - JOUR AU - Martin, S. S. AU - Blaha, M. J. AU - Toth, P. P. AU - Joshi, P. H. AU - McEvoy, J. W. AU - Ahmed, H. M. AU - Elshazly, M. B. AU - Swiger, K. J. AU - Michos, E. D. AU - Kwiterovich, P. O. AU - Kulkarni, K. R. AU - Chimera, J. AU - Cannon, C. P. AU - Blumenthal, R. S. AU - Jones, S. R. PY - 2013 DA - 2013// TI - Very large database of lipids: rationale and design JO - Clin Cardiol VL - 36 UR - https://doi.org/10.1002/clc.22214 DO - 10.1002/clc.22214 ID - Martin2013 ER - TY - JOUR AU - Martin, S. S. AU - Blaha, M. J. AU - Elshazly, M. B. AU - Toth, P. P. AU - Kwiterovich, P. O. AU - Blumenthal, R. S. AU - Jones, S. R. PY - 2013 DA - 2013// TI - Comparison of a novel method vs the friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile JO - JAMA VL - 310 UR - https://doi.org/10.1001/jama.2013.280532 DO - 10.1001/jama.2013.280532 ID - Martin2013 ER - TY - JOUR AU - Planella, T. AU - Cortés, M. AU - Martínez-Brú, C. AU - González-Sastre, F. AU - Ordóñez-Llanos, J. PY - 1997 DA - 1997// TI - Calculation of LDL-cholesterol by using apolipoprotein B for classification of nonchylomicronemic dyslipemia JO - Clin Chem VL - 43 ID - Planella1997 ER - TY - JOUR AU - Björkegren, J. AU - Karpe, F. AU - Milne, R. W. AU - Hamsten, A. PY - 1998 DA - 1998// TI - Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma JO - J Lipid Res VL - 39 ID - Björkegren1998 ER - TY - JOUR AU - Hermans, M. P. AU - Sacks, F. M. AU - Ahn, S. A. AU - Rousseau, M. F. PY - 2011 DA - 2011// TI - Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: discriminant Ratio and unbiased equivalence JO - Cardiovasc Diabetol VL - 10 UR - https://doi.org/10.1186/1475-2840-10-20 DO - 10.1186/1475-2840-10-20 ID - Hermans2011 ER - TY - JOUR AU - Bairaktari, E. AU - Hatzidimou, K. AU - Tzallas, C. AU - Vini, M. AU - Katsaraki, A. AU - Tselepis, A. AU - Elisaf, M. AU - Tsolas, O. PY - 2000 DA - 2000// TI - Estimation of LDL cholesterol based on the friedewald formula and on apo B levels JO - Clin Biochem VL - 33 UR - https://doi.org/10.1016/S0009-9120(00)00162-4 DO - 10.1016/S0009-9120(00)00162-4 ID - Bairaktari2000 ER - TY - JOUR AU - Martin, S. S. AU - Blaha, M. J. AU - Elshazly, M. B. AU - Brinton, E. A. AU - Toth, P. P. AU - McEvoy, J. W. AU - Joshi, P. H. AU - Kulkarni, K. R. AU - Mize, P. D. AU - Kwiterovich, P. O. AU - Defilippis, A. P. AU - Blumenthal, R. S. AU - Jones, S. R. PY - 2013 DA - 2013// TI - Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications JO - J Am Coll Cardiol VL - 62 UR - https://doi.org/10.1016/j.jacc.2013.01.079 DO - 10.1016/j.jacc.2013.01.079 ID - Martin2013 ER - TY - JOUR AU - Levy, J. C. AU - Morris, R. J. AU - Hammersley, M. AU - Turner, R. C. PY - 1999 DA - 1999// TI - Discrimination, adjusted correlation, and equivalence of imprecise tests: application to glucose tolerance JO - Am J Physiol VL - 276 ID - Levy1999 ER - TY - JOUR AU - Hermans, M. P. AU - Levy, J. C. AU - Morris, R. J. AU - Turner, R. C. PY - 1999 DA - 1999// TI - Comparison of insulin sensitivity tests across a range of glucose tolerance form normal to diabetes JO - Diabetologia VL - 42 UR - https://doi.org/10.1007/s001250051215 DO - 10.1007/s001250051215 ID - Hermans1999 ER - TY - JOUR AU - Alberti, K. G. AU - Eckel, R. H. AU - Grundy, S. M. AU - Zimmet, P. Z. AU - Cleeman, J. I. AU - Donato, K. A. AU - Fruchart, J. C. AU - James, W. P. AU - Loria, C. M. AU - Smith, S. C. PY - 2009 DA - 2009// TI - International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity JO - Circulation VL - 120 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.192644 DO - 10.1161/CIRCULATIONAHA.109.192644 ID - Alberti2009 ER - TY - JOUR AU - Levey, A. S. AU - Bosch, J. P. AU - Lewis, J. B. AU - Greene, T. AU - Rogers, N. AU - Roth, D. PY - 1999 DA - 1999// TI - A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group JO - Ann Intern Med VL - 130 UR - https://doi.org/10.7326/0003-4819-130-6-199903160-00002 DO - 10.7326/0003-4819-130-6-199903160-00002 ID - Levey1999 ER - TY - JOUR AU - Hermans, M. P. AU - Ahn, S. A. AU - Rousseau, M. F. PY - 2012 DA - 2012// TI - The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetes JO - J Diabetes Complications VL - 26 UR - https://doi.org/10.1016/j.jdiacomp.2012.03.014 DO - 10.1016/j.jdiacomp.2012.03.014 ID - Hermans2012 ER - TY - JOUR AU - Kothari, V. AU - Stevens, R. J. AU - Adler, A. I. AU - Stratton, I. M. AU - Manley, S. E. AU - Neil, H. A. AU - Holman, R. R. PY - 2002 DA - 2002// TI - UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective diabetes study risk engine JO - Stroke VL - 33 UR - https://doi.org/10.1161/01.STR.0000020091.07144.C7 DO - 10.1161/01.STR.0000020091.07144.C7 ID - Kothari2002 ER - TY - JOUR AU - Hermans, M. P. AU - Ahn, S. A. AU - Rousseau, M. F. PY - 2010 DA - 2010// TI - Log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males JO - Cardiovasc Diabetol VL - 9 UR - https://doi.org/10.1186/1475-2840-9-88 DO - 10.1186/1475-2840-9-88 ID - Hermans2010 ER - TY - JOUR AU - Hermans, M. P. AU - Ahn, S. A. AU - Rousseau, M. F. PY - 2012 DA - 2012// TI - The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, β-cell function loss and microangiopathy in type 2 diabetes females JO - Lipids Health Dis VL - 11 UR - https://doi.org/10.1186/1476-511X-11-132 DO - 10.1186/1476-511X-11-132 ID - Hermans2012 ER - TY - JOUR AU - Querton, L. AU - Buysschaert, M. AU - Hermans, M. P. PY - 2012 DA - 2012// TI - Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels JO - J Clin Lipidol VL - 6 UR - https://doi.org/10.1016/j.jacl.2012.04.002 DO - 10.1016/j.jacl.2012.04.002 ID - Querton2012 ER - TY - JOUR AU - Murase, T. AU - Okubo, M. AU - Takeuchi, I. PY - 2010 DA - 2010// TI - Non-HDL-cholesterol/apolipoprotein B ratio: a useful distinguishing feature in the screening for type III hyperlipoproteinemia JO - J Clin Lipidol VL - 4 UR - https://doi.org/10.1016/j.jacl.2010.01.004 DO - 10.1016/j.jacl.2010.01.004 ID - Murase2010 ER - TY - CHAP AU - Hermans, M. P. AU - Ahn, S. A. AU - Rousseau, M. F. AU - Zimering, M. B. PY - 2011 DA - 2011// TI - Residual vascular risk in T2DM: the next frontier BT - Recent Advances in the Pathogenesis, Prevention and Management of Type 2 Diabetes and its Complications PB - Intech CY - Rijeka (Croatia) ID - Hermans2011 ER - TY - JOUR AU - Bestehorn, K. AU - Smolka, W. AU - Pittrow, D. AU - Schulte, H. AU - Assmann, G. PY - 2010 DA - 2010// TI - Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007995.2010.532088 DO - 10.1185/03007995.2010.532088 ID - Bestehorn2010 ER - TY - JOUR AU - Fruchart, J. C. AU - Sacks, F. M. AU - Hermans, M. P. PY - 2010 DA - 2010// TI - International Steering Committee of R(3)i. Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i) JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007995.2010.489341 DO - 10.1185/03007995.2010.489341 ID - Fruchart2010 ER - TY - JOUR AU - Reyes-Soffer, G. AU - Ngai, C. I. AU - Lovato, L. AU - Karmally, W. AU - Ramakrishnan, R. AU - Holleran, S. AU - Ginsberg, H. N. PY - 2013 DA - 2013// TI - Effect of combination therapy with fenofibrate and simvastatin on postprandial lipemia in the ACCORD lipid trial JO - Diabetes Care VL - 36 UR - https://doi.org/10.2337/dc11-2556 DO - 10.2337/dc11-2556 ID - Reyes-Soffer2013 ER - TY - JOUR AU - Hermans, M. P. AU - Ahn, S. A. AU - Rousseau, M. F. PY - 2007 DA - 2007// TI - The non-HDL-C/HDL-C ratio provides cardiovascular risk stratification similar to the ApoB/ApoA1 ratio in diabetics: Comparison with reference lipid markers JO - Diabetes Metab Syndr VL - 1 UR - https://doi.org/10.1016/j.dsx.2006.11.003 DO - 10.1016/j.dsx.2006.11.003 ID - Hermans2007 ER - TY - JOUR AU - Tenenbaum, A. AU - Fisman, E. Z. PY - 2012 DA - 2012// TI - Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction JO - Cardiovasc Diabetol VL - 11 UR - https://doi.org/10.1186/1475-2840-11-125 DO - 10.1186/1475-2840-11-125 ID - Tenenbaum2012 ER - TY - JOUR AU - Fruchart, J. C. AU - Davignon, J. AU - Hermans, M. P. AU - Al-Rubeaan, K. AU - Amarenco, P. AU - Assmann, G. AU - Barter, P. AU - Betteridge, J. AU - Bruckert, E. AU - Cuevas, A. AU - Farnier, M. AU - Ferrannini, E. AU - Fioretto, P. AU - Genest, J. AU - Ginsberg, H. N. AU - Gotto, A. M. AU - Hu, D. AU - Kadowaki, T. AU - Kodama, T. AU - Krempf, M. AU - Matsuzawa, Y. AU - Núñez-Cortés, J. M. AU - Monfil, C. C. AU - Ogawa, H. AU - Plutzky, J. AU - Rader, D. J. AU - Sadikot, S. AU - Santos, R. D. AU - Shlyakhto, E. AU - Sritara, P. AU - Sy, R. AU - Tall, A. AU - Tan, C. E. AU - Tokgözoğlu, L. AU - Toth, P. P. AU - Valensi, P. AU - Wanner, C. AU - Zambon, A. AU - Zhu, J. AU - Zimmet, P. PY - 2014 DA - 2014// TI - Residual risk reduction initiative (R3i). Residual macrovascular risk in 2013: what have we learned? JO - Cardiovasc Diabetol VL - 13 UR - https://doi.org/10.1186/1475-2840-13-26 DO - 10.1186/1475-2840-13-26 ID - Fruchart2014 ER -